7WBN image
Deposition Date 2021-12-17
Release Date 2022-10-26
Last Version Date 2024-05-15
Entry Detail
PDB ID:
7WBN
Title:
PDB structure of RevCC
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Conformers Calculated:
200
Conformers Submitted:
20
Selection Criteria:
structures with the least restraint violations
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:RevCC
Chain IDs:A
Chain Length:98
Number of Molecules:1
Biological Source:Human immunodeficiency virus 1
Ligand Molecules
Primary Citation
Pseudo-Isolated alpha-Helix Platform for the Recognition of Deep and Narrow Targets.
J.Am.Chem.Soc. 144 15519 15528 (2022)
PMID: 35972994 DOI: 10.1021/jacs.2c03858

Abstact

Although interest in stabilized α-helical peptides as next-generation therapeutics for modulating biomolecular interfaces is increasing, peptides have limited functionality and stability due to their small size. In comparison, α-helical ligands based on proteins can make steric clash with targets due to their large size. Here, we report the design of a monomeric pseudo-isolated α-helix (mPIH) system in which proteins behave as if they are peptides. The designed proteins contain α-helix ligands that do not require any covalent chemical modification, do not have frayed ends, and importantly can make sterically favorable interactions similar to isolated peptides. An optimal mPIH showed a more than 100-fold increase in target selectivity, which might be related to the advantages in conformational selection due to the absence of frayed ends. The α-helical ligand in the mPIH displayed high thermal stability well above human body temperature and showed reversible and rapid folding/unfolding transitions. Thus, mPIH can become a promising protein-based platform for developing stabilized α-helix pharmaceuticals.

Legend

Protein

Chemical

Disease

Primary Citation of related structures